Effect of Zumba Training on Quality of Life, Love of Life, and Psychological Resilience (Zumba and QOL)

April 6, 2026 updated by: Coşkun YILMAZ, Gümüşhane Universıty
This randomized controlled trial aimed to investigate the effects of a structured 6-week Zumba exercise program on psychological resilience, quality of life, and love of life in sedentary young adult women. Participants were randomly assigned to either a Zumba intervention group or a control group maintaining a sedentary lifestyle. Outcomes were assessed using validated psychometric scales before and after the intervention

Study Overview

Detailed Description

The study was designed as a parallel-group, two-arm randomized controlled trial using a pre-test/post-test design. A total of 36 sedentary women aged 18-25 years were randomized into either a Zumba group (n=18) or a control group (n=18). The intervention consisted of a progressive Zumba training program conducted three times per week for six weeks, with each session lasting 60 minutes.

Primary outcomes included psychological resilience, assessed using the Brief Psychological Resilience Scale (BPRS), while secondary outcomes included quality of life (SF-12) and love of life (LLS). A 2×2 mixed-design ANOVA was used to analyze group-by-time interactions.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane
      • Gümüşhane, Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane, Turkey (Türkiye), 29600
        • Gumushane Univetsity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Female participants aged 18-25 years
  • Sedentary (less than 60 min/week physical activity in last 6 months)

Exclusion Criteria:

  • Musculoskeletal injuries
  • Chronic diseases
  • Diagnosed psychological disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Zumba Exercise Group
Participants engaged in a structured Zumba exercise program for 6 weeks (3 sessions/week, 60 minutes/session). Intervention Type: Behavioral.
Participants engaged in a structured Zumba exercise program for 6 weeks (3 sessions/week, 60 minutes/session).
Other Names:
  • Zumba exercise
Participants maintained their usual sedentary lifestyle with no additional exercise.
Other Names:
  • usual sedentary lifestyle with no additional exercise
No Intervention: Control Group
Participants maintained their usual sedentary lifestyle with no additional exercise. Usual sedentary lifestyle with no additional exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological Resilience
Time Frame: 6 weeks

Measure: Brief Psychological Resilience Scale. Total scores range from 6 to 30, with higher aggregate scores reflecting a superior capacity to 'bounce back' and higher levels of psychological resilience.

Time Frame: Pre-test and Post-test

6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life
Time Frame: 6 Weeks

Measure: Quality of Life Scale. It is a comprehensive self-report quality of life questionnaire consisting of 12 questions that measures individuals' physical and mental health status and its impact on daily life.

Components: Physical and Mental score Scores range from 0 to 100, with higher values representing superior health-related quality of life.

6 Weeks
Love of Life
Time Frame: 6 weeks
Measure: Love of Life Scale. Participants' general positive attitude toward life and their perceived enjoyment of living were assessed using the Love of Life Scale (LLS). This 16-item instrument comprises three distinct factors: Positive Attitude Toward Life (PAWL) (8 items; e.g., 'Life is full of pleasure'), Happy Results of Love of Life (HRLL) (4 items; e.g., 'I want a long life to realize what I hope for'), and Meaning of Life (ML) (4 items). Responses are recorded on a 5-point Likert-type scale ranging from 1 (not at all) to 5 (very much), where higher aggregate scores indicate a more profound sense of existential meaning, happiness, and a positive outlook on life.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2025

Primary Completion (Actual)

November 5, 2025

Study Completion (Actual)

November 20, 2025

Study Registration Dates

First Submitted

March 31, 2026

First Submitted That Met QC Criteria

March 31, 2026

First Posted (Actual)

April 7, 2026

Study Record Updates

Last Update Posted (Actual)

April 9, 2026

Last Update Submitted That Met QC Criteria

April 6, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2025/0477
  • AEA RCT Registry (Other Identifier: RCT ID: AEARCTR-0018094)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be publicly shared due to privacy and confidentiality concerns. The dataset contains sensitive personal and psychological information that could potentially lead to participant identification. Data may be made available upon reasonable request to the corresponding author, subject to ethical approval and data protection regulations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Experimental Group

Subscribe